drugset / Trial / NCT00918398
AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations
RandomizedCrossoverOpen-labelBasic science
Summary
The primary objective is to investigate the pharmacokinetics of AZD1981 given in different formulations and to measure renal clearance
Timeline
- Start
- 2009-06
- Primary completion
- —
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1981 | Small molecule | 100 mg | Intravenous |
| Subject | AZD1981 | Small molecule | 500 mg | Intravenous |
| Subject | AZD1981 | Small molecule | 514 mg | Intravenous |
Indications
No indication recorded.